Rat (repeat-dose) and cynomolgus monkey (single-dose safety pharmacology)
“Animal studies exploring the safety of dinutuximab were conducted in Sprague Dawley rats and cynomolgus monkeys.”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Why that species
Antibody binds GD2 in rats and lowers mechanical pain thresholds; TCR staining consistent with GD2 expression in rat and rabbit
“Though there were no histopathological indications of an effect of dinutuximab on peripheral nerves in this study, ch14.18 has been shown to bind to GD2 in rats.”
✓ VerifiedFDA pharmacology/toxicology review, p. 12Source ↗
Surrogate molecule
No surrogate; the clinical antibody was tested in rats and cynomolgus monkeys
“Animal studies exploring the safety of dinutuximab were conducted in Sprague Dawley rats and cynomolgus monkeys.”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗